Two drug applications are withdrawn from the EMEA

Two drug applications that were under review by the European Medicine Agency’s main scientific committee have been withdrawn by their sponsors following the committee’s request for more data.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom